SCHEMBL17802259

SCHEMBL17802259

CC(C)c1cnc2c(O)c([N+](=O)[O-])ccn2c1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.36
▸ CYP1A2 P05177 3/20 0.36
▸ CYP2C9 P11712 3/20 0.36
▸ CYP2C19 P33261 2/20 0.36
▸ MAPT P10636 7/20 0.36
▸ GPR35 Q9HC97 2/20 0.36
▸ PDK1 Q15118 1/20 0.34
▸ MEN1 O00255 3/20 0.34
▸ KMT2A Q03164 3/20 0.34
▸ LMNA P02545 2/20 0.34
▸ HTT P42858 2/20 0.34
▸ HPGD P15428 1/20 0.34
▸ KDM4E B2RXH2 2/20 0.33
▸ CTSB P07858 2/20 0.33
▸ TDP1 Q9NUW8 2/20 0.33
▸ CASP6 P55212 2/20 0.33
▸ GAA P10253 1/20 0.33
▸ IDO1 P14902 1/20 0.33
▸ TDO2 P48775 1/20 0.33
▸ KDM5A P29375 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19365016 0.88 KDM5A (0.34) MAPTKDM5A
SCHEMBL19361129 0.85 KDM5A (0.32) KDM5A
SCHEMBL19365017 0.79 KDM5A (0.37) ALDH1A1CYP1A2MAPTLMNAHPGD
SCHEMBL10027232 0.78 KDM5A (0.36) ALDH1A1CYP1A2LMNAHPGDKDM4E
SCHEMBL17802285 0.78 KDM5A (0.36) ALDH1A1CYP1A2LMNAHPGDKDM4E
SCHEMBL17808751 0.76 RPS6KA3 (0.37) ALDH1A1MAPTKDM5ANPC1RAB9A
SCHEMBL17808923 0.76 MAPT (0.39) ALDH1A1MAPTLMNAKDM5ACYP2D6
SCHEMBL17808905 0.75 KDM5B (0.38) ALDH1A1MAPTMEN1KMT2ALMNA
SCHEMBL19361112 0.75 TP53 (0.39) ALDH1A1MAPTLMNAHPGDNPC1
SCHEMBL17808756 0.75 PTGS1 (0.36) ALDH1A1CYP1A2MAPTHPGDKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3227292-B1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS ALTERITY THERAPEUTICS LTD (AU) 2022-03-09 — — EP disclosed
US-20210230159-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2021-07-29 — — US disclosed
US-11008319-B2 4H-pyrido[1,2-a]pyrimidin-4-one compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2021-05-18 — — US disclosed
CN-111961050-A 4H-pyrido [1,2-a ] pyrimidin-4-one compounds 普拉纳生物技术有限公司 2020-11-20 — — CN disclosed
US-20200317670-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2020-10-08 — — US disclosed
CN-107001360-B 4H-pyrido [1,2-a ] pyrimidin-4-one compounds 普拉纳生物技术有限公司 2020-09-18 — — CN disclosed
US-10738050-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2020-08-11 — — US disclosed
US-20190352301-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2019-11-21 — — US disclosed
US-10287285-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PRANA BIOTECHNOLOGY LIMITED (AU) 2019-05-14 — — US disclosed
EP-3227292-A1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS Prana Biotechnology Ltd (AU) 2017-10-11 — — EP disclosed
US-20170267676-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2017-09-21 — — US disclosed
US-20170267676-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2017-09-21 — — US disclosed
WO-2016086261-A1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2016-06-09 — — WO disclosed
WO-2016086261-A1 4H-PYRIDO[1,2-a]PYRIMIDIN-4-ONE COMPOUNDS PRANA BIOTECHNOLOGY LIMITED (AU) 2016-06-09 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738050-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885
US-20200317670-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885
US-10287285-B2 4H-pyrido[1,2-A]pyrimidin-4-one compounds PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885
US-11008319-B2 4H-pyrido[1,2-a]pyrimidin-4-one compounds PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885
US-20190352301-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885
US-20210230159-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885
US-20170267676-A1 4H-PYRIDO[1,2-A]PYRIMIDIN-4-ONE COMPOUNDS PSEN2, PSEN1, PNPO ALDH1A1 299/4885CYP1A2 80/4885CYP2C9 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback